Sutro Biopharma (STRO) Net Cash Flow Growth (1y) (2018 - 2025)
Sutro Biopharma (STRO) Net Cash Flow Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 301.06% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | -149.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -149.58% |
| Sep 30, 2025 | -97.73% |
| Jun 30, 2025 | -265.05% |
| Mar 31, 2025 | -1,968.27% |
| Dec 31, 2024 | 225.15% |
| Sep 30, 2024 | 154.67% |
| Jun 30, 2024 | -85.19% |
| Mar 31, 2024 | -126.71% |
| Dec 31, 2023 | 74.63% |
| Sep 30, 2023 | -967.65% |
| Jun 30, 2023 | 243.77% |
| Mar 31, 2023 | 1,105.82% |
| Dec 31, 2022 | -16,802.73% |
| Sep 30, 2022 | 168.77% |
| Jun 30, 2022 | 8,648.08% |
| Mar 31, 2022 | 98.99% |
| Dec 31, 2021 | -100.21% |
| Sep 30, 2021 | -21,127.27% |
| Jun 30, 2021 | -97.36% |
| Mar 31, 2021 | -489.42% |